The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Resolution of the anel of Expert on Diagnostics, Prevention, and Treatment of Venous Thromboembolism (VTE) in Patients with Malignant Neoplasms

Journal: Journal of Venous Disorders. 2018;12(1): 57‑59

DOI: 10.17116/flebo201812157-59

Views: 1790

Downloaded: 122

Download PDF (RU)
Contact the author
Table of contents

RESOLUTION OF THE ANEL OF EXPERT ON DIAGNOSTICS, PREVENTION, AND TREATMENT OF VENOUS THROMBOEMBOLISM (VTE) IN PATIENTS WITH MALIGNANT NEOPLASMS
RESOLUTION OF THE ANEL OF EXPERT ON DIAGNOSTICS, PREVENTION, AND TREATMENT OF VENOUS THROMBOEMBOLISM (VTE) IN PATIENTS WITH MALIGNANT NEOPLASMS

To cite this article:

Resolution of the anel of Expert on Diagnostics, Prevention, and Treatment of Venous Thromboembolism (VTE) in Patients with Malignant Neoplasms. Journal of Venous Disorders. 2018;12(1):57‑59. (In Russ.)
https://doi.org/10.17116/flebo201812157-59

Подписка 2025-2 (Journal of Venous Disorders)
 
МСФ на ЯМ
Close metadata

List of references:

  1. Rossiisckie klinicheskie recomendacii po diagnostike, lecheniyu i profilaktike venosnych tromboembolicheskich oslojnenii. Flebologiya. 2015;4:9:2:1-52. (In Russ.)
  2. Ay C, Dunkler D, Marosi C et al. Prediction of venous thromboembolism in cancer patients. Blood. 2010;116:5377-5382.
  3. Ihaddadene R, Corsi DJ, Lazo-Langner A, Shivakumar S, Zarychanski R, Tagalakis V, et al. Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism. Blood. 2016 Apr 21;127:2035-2037.
  4. Carrier M, Khorana AA, Zwicker JI, Lyman GH, Le Gal G, Lee AY, subcommittee on Haemostasis and Malignancy for the SSC of the ISTH. Venous thromboembolism in cancer clinical trials: recommendation for standardized reporting and analysis. J Thromb Haemost. 2012;10:2599-2601.
  5. Streiff MB, Holmstrom B, Ashrani A, et al. Cancer-associated venous thromboembolic disease, version 1.2015. J Natl Compr Canc Netw. 2015;13:1079-1095.
  6. Timp JF, Braekkan SK, Versteeg HH, Cannegieter S.C. Epidemiology of cancer-associated venous thrombosis. Blood. 2013 Sep 5;122:1712-1723.
  7. Trinh VQ, Karakiewicz PI, Sammon J, et al. Venous thromboembolism after major cancer surgery: temporal trends and patterns of care. JAMA Surg. 2014;149:43-49.
  8. Van der Hulle T, den Exter PL, Planquette B, et al. Risk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism among treated and untreated patients: a pooled analysis of 926 patients. J Thromb Haemost. 2016;14:105-113.
  9. Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost. 2007;5:632-634.
  10. Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008;111:4902-4907.
  11. Timp JF, Braekkan SK, Versteeg HH, Cannegieter SC. Epidemiology of cancer-associated venous thrombosis. Blood. 2013;122:1712-1723.
  12. Watson HG, Keeling DM, Laffan M, Tait RC, Makris M. Guideline on aspects of cancer-related venous thrombosis. Br J Haematol. 2015;170:640-648.
  13. Di Nisio M, Ferrante N, De Tursi M, et al. Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy. J Thromb Haemost. 2010;104:1049-1054.
  14. Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic Therapy for VTE Disease: antithrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e419S-e494S. https://doi.org/10.1378/chest.11-2301
  15. Kearon C, Akl EA, Ornelas, J et al. Antithrombotic therapy for vte disease: chest guideline and expert panel report. Chest. 2016;149(2):315-352. https://doi.org/10.1016/j.chest.2015.11.026
  16. Khorana A, Carrier M, Garcia D, Lee AY. Guidance for the prevention and treatment of cancer-associated venous thromboembolism. J Thromb Thrombolysis. 2016;41:81-91.
  17. Carrier M, Cameron C, Delluc A, Castellucci L, Khorana AA, Lee AY. Efficacy and safety of anticoagulant therapy for the treatment of acute cancer-associated thrombosis: a systematic review and metaanalysis. Thromb Res. 2014;134(6):1214-1219.
  18. Vedovati MC, Germini F, Agnelli G, Becattini C. Direct oral anticoagulants in patients with VTE and cancer: a systematic review and metaanalysis. Chest. 2015;147(2):475-483.
  19. Farge D, Debourdeau P, Beckers M, et al. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost. 2013;11:56-70.
  20. Farge D, Bounameaux H, Brenner B, Cajfinger F, Debourdeau P, Khorana AA, Pabinger I, Solymoss S, Douketis J, Kakkar A. International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer. Lancet Oncol. 2016;17: e452-e466.
  21. Franchini M, Bonfanti C, Lippi G. Cancer-associated thrombosis: investigating the role of new oral anticoagulants. Thromb Res. 2015;135(5):777-781.
  22. Napolitano M, Saccullo G, Malato A, et al. Optimal duration of low molecular weight heparin for the treatment of cancer-related deep vein thrombosis: the Cancer-DACUS Study. J Clin Oncol. 2014;32(32):3607-3612.
  23. Easaw JC, Shea-Budgell MA, Wu CM, et al. Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment. Curr Oncol. 2015;22:144-155.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.